Your session is about to expire
← Back to Search
TENS for Endometriosis Pain
N/A
Recruiting
Led By Kristin W Riley, MD
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
A surgical diagnosis with direct visualization and/or histopathologic confirmation of endometriosis
Females ages 18-45 years at time of enrollment
Must not have
Post-operative <12 weeks from abdominal or pelvic surgery
TENS device exclusion: Cardiac arrhythmia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline period (months 1-3) and treatment period (months 4-6)
Awards & highlights
No Placebo-Only Group
Summary
This trial will help researchers see if TENS units help decrease endometriosis flare pain.
Who is the study for?
This trial is for women aged 18-45 who have been diagnosed with endometriosis through surgery or tissue examination, experience monthly pain flares from it, and have never used a TENS unit. It's not for those with pacemakers, heart rhythm problems, open skin sores where the device goes, or if pregnant/nursing/trying to conceive. Participants must speak and understand English.
What is being tested?
The study tests whether a TENS (Transcutaneous Electrical Nerve Stimulation) unit can reduce pain during endometriosis flare-ups. For three months participants will track their pain without the device; then they'll use the TENS unit for another three months while recording their symptoms.
What are the potential side effects?
While using a TENS unit is generally safe, potential side effects may include skin irritation at the site of electrode placement and discomfort or muscle twitching during use.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My endometriosis was confirmed through surgery or biopsy.
Select...
I am a woman aged between 18 and 45.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I had surgery in my abdomen or pelvis less than 12 weeks ago.
Select...
I do not have an irregular heartbeat.
Select...
I do not have open skin sores where a TENS device would be placed.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline period (months 1-3) and treatment period (months 4-6)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline period (months 1-3) and treatment period (months 4-6)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Average Daily VAS Pain Score
Secondary study objectives
Change in Female Sexual Function Index Total Score using the FSFI questionnaire
Change in Quality of Life Score from baseline to end of study using the EHP30 questionnaire
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: No TENS unit useActive Control1 Intervention
All subjects will start with 3 months of no TENS use and diary tracking
Group II: TENS unit useActive Control1 Intervention
All subjects will then have 3 months of TENS use during episodes of endometriosis pain flare and diary tracking.
Find a Location
Who is running the clinical trial?
Milton S. Hershey Medical CenterLead Sponsor
511 Previous Clinical Trials
2,870,820 Total Patients Enrolled
7 Trials studying Endometriosis
566 Patients Enrolled for Endometriosis
Kristin W Riley, MDPrincipal InvestigatorPenn State Health Hershey Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My endometriosis was confirmed through surgery or biopsy.I had surgery in my abdomen or pelvis less than 12 weeks ago.I experience frequent endometriosis pain flares monthly.I am not planning any surgery or changes to my hormonal medications during the study.I do not have an irregular heartbeat.I do not have open skin sores where a TENS device would be placed.I am a woman aged between 18 and 45.You have never used a TENS (transcutaneous electrical nerve stimulation) device before.
Research Study Groups:
This trial has the following groups:- Group 1: No TENS unit use
- Group 2: TENS unit use
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.